The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Novo Nordisk’s weight loss drug, Wegovy, for the prevention of serious cardiovascular events in overweight and obese adults. This landmark decision marks the first time a GLP-1 obesity drug is prescribed for such a purpose in the UK, following a similar approval by the… Continue reading Novo Nordisk’s Wegovy approved by MHRA in the UK for cardiovascular prevention
Stock Research
Lack of charging infrastructure hinders electric vehicle adoption in Europe, new poll reveals
A recent Statista Consumer Insights poll has highlighted a major obstacle to electric vehicle (EV) adoption across Europe: inadequate charging infrastructure. The survey reveals that over 20% of potential EV buyers in various northern and western European countries view poor electric infrastructure as a significant deterrent. Regional discrepancies in infrastructure challenges The survey data shows… Continue reading Lack of charging infrastructure hinders electric vehicle adoption in Europe, new poll reveals
Citi upgrades Coinbase stock to Buy with $345 target: Is a 30% gain within reach?
Coinbase Global Inc. (NASDAQ: COIN) received an upgrade today from Citi analyst Peter Christiansen, who shifted the stock from a Neutral/High-Risk rating to a Buy/High-Risk rating. Along with this upgrade, he increased his price target on the stock to $345 from $260, indicating a potential 30% rise from its current price. Analyst ratings and market… Continue reading Citi upgrades Coinbase stock to Buy with $345 target: Is a 30% gain within reach?
BofA double upgrades CH Robinson Worldwide to Buy: Should you invest?
In the ever-evolving logistics sector, C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) has recently been garnering a lot of attention due to a positive shift in analysts’ sentiments. On July 22, it received a double upgrade from Bank of America (BofA), propelling it directly to a “Buy” from an “Underperform” rating. This significant shift in… Continue reading BofA double upgrades CH Robinson Worldwide to Buy: Should you invest?
Coca-Cola raises full-year outlook as global demand increases in Q2
Coca-Cola has announced an increase in its full-year outlook, attributing the rise to robust global demand for its beverages during the second quarter of 2024. The company has adjusted its forecast for organic revenue growth to 9% to 10%, up from the previous 8% to 9%. The outlook for comparable earnings growth has been raised… Continue reading Coca-Cola raises full-year outlook as global demand increases in Q2
UPS Q2 earnings prove it overpays its drivers, investors flee
United Parcel Service Inc. (NYSE:UPS) reported its Q2 earnings today. The stock is trading down 12% after market open, mainly due to lower-than-expected revenue in its domestic business. On a more positive note, US volumes increased for the first time in 9 quarters. That wasn’t enough to please the investors though, who continue to sell… Continue reading UPS Q2 earnings prove it overpays its drivers, investors flee
